Know Labs (KNW): Utang-utang marang kapitalisasi buku

Logo grafis Know Labs (KNW)

Know Labs, Inc. (KNW) aims to become a MedTech leader by developing AI systems for non-invasive glucose analysis. The total debt-to-market capitalization ratio reflects current progress, with the metric holding around 0.00. The execution of the plan depends on FDA approval and a steady influx of investment. However, the path to commercialization is complicated by intense pressure from industry behemoths and high barriers to entry.

Rasio utang-utang marang kapitalisasi buku Know Labs Corporation (KNW): kanggo periode 28.04.2023 - 15.08.2025
Sampel barang Know Labs Corporation

To filter financial risks, Know Labs, Inc. (KNW) must evaluate its debt load. This metric is calculated as the ratio of total liabilities to the sum of equity and debt. Analyzing the ratio of borrowed funds to book capitalization allows for the determination of the business's degree of dependence on creditors. An increase in this indicator signals rising leverage. For an R&D center developing RF glucose monitoring sensors, low debt is critical for maintaining patent independence.

Pesaing Know Labs, Inc.

Rasio utang marang kapitalisasi buku DexCom, Inc.|Rasio utang marang aset resik penumbrainc.com PEN|Novanta - Utang-utang marang kapitalisasi buku|HAE: Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku Inspire Sleep (INSP)|Procept (PRCT) - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku CNMD (CONMED Corporation)|Utang-utang marang nilai buku pulsebiosciences.com (PLSE)|Utang marang nilai buku INMD|Utang-utang marang kapitalisasi buku Picard Medical Corp PMI|Utang marang nilai buku Surmodics Corp (SRDX)|Utang marang modal buku Senseonics SENS|Utang-utang marang kapitalisasi buku NPCE (NeuroPace, Inc.)|TCMD - Utang-utang marang aset resik|SNWV (SANUWAVE) - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Outset Medical Inc|ELMD - Utang marang nilai buku|Rasio utang marang aset resik LNSR|Rasio utang marang kapitalisasi buku RCEL (AVITA Medical, Inc.)|Utang marang nilai buku profoundmedical.com (PROF)|BDMD: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku EDAP TMS SA EDAP|Bovie Medical (APYX) - Utang-utang marang kapitalisasi buku|ICCM - Rasio utang marang nilai buku|pulmonx.com - Utang-utang marang kapitalisasi buku|TELA Bio (TELA) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku CTSO|Utang marang nilai buku Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ZYXI|Utang-utang marang kapitalisasi buku ECOR (electrocore.com)|Rasio utang marang kapitalisasi buku Vicarious Surgical RBOT|IINN - Rasio utang marang kapitalisasi buku|Utang marang nilai buku SeaStar Medical (ICU)|IRIX - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku INBS|XAIR (Beyond Air) - Utang-utang marang nilai buku|Profusa Inc - Rasio utang marang kapitalisasi buku|Utang marang aset resik STRATA Skin (SSKN)|Utang marang nilai buku GCTK|Utang-utang marang kapitalisasi buku NanoVibronix Inc. (NAOV)|Utang-utang marang kapitalisasi buku VERO|Nuwellis Corp - Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Aethlon Medical|ASXC: Rasio utang-utang marang kapitalisasi buku|AVGR (Avinger) - Rasio utang marang kapitalisasi buku|biosig.com (BSGM) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku CUTR (Cutera, Inc)|Utang-utang marang nilai buku NARI|Rasio utang marang kapitalisasi buku Nevro Corp. NVRO|Rasio utang marang nilai buku reshapelifesciences.com RSLS|Utang marang nilai buku Silk Road Medical (SILK)